SEARCH

SEARCH BY CITATION

  • 1
    Seya, T., Turner, J. R. and Atkinson, J. P., Purification and characterization of a membrane protein (gp45–70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 1986. 163: 837855.
  • 2
    Seya, T. and Atkinson, J. P., Functional properties of membrane cofactor protein of complement. Biochem. J. 1989. 264: 581588.
  • 3
    Liszewski, M. K., Post, T. W. and Atkinson, J. P., Membrane cofactor protein (MCP or CD46): Newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 1991. 9: 431455.
  • 4
    Liszewski, M. K., Post, T. W. and Atkinson, J. P., Control of the complement system. Adv. Immunol. 1996. 61: 201283.
  • 5
    Lublin, D. M., Liszewski, M. K., Post, T. W., Arce, M. A., Le Beau, M. M., Rebentisch, M. B., Lemons, R. S., Seya, T. and Atkinson, J. P., Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). J. Exp. Med. 1988. 168: 181194.
  • 6
    Post, T. W., Liszewski, M. K., Adams, E. M., Tedja, I., Miller, E. A. and Atkinson, J. P., Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms which correlate with protein phenotype. J. Exp. Med. 1991. 174: 93102.
  • 7
    Russell, S. M., Sparrow, R. L., McKenzie, I. F. C. and Purcell, D. F. J., Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur. J. Immunol. 1992. 22: 15131518.
  • 8
    Lindahl, G., Sjöbring, U. and Johnsson, E., Human complement regulators: A major target for pathogenic microorganisms. Curr. Opinion Immunol. 2000. 12: 4451.
  • 9
    Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B. and Rabourdin-Combe, C., Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 1993. 67: 60256023.
  • 10
    Dorig, R. E., Marcil, A., Chopra, A. and Richardson, C. D., The human CD46 molecule is a receptor for measles virus. Cell 1993. 75: 295305.
  • 11
    Källström, H., Liszewski, M. K., Atkinson, J. P. and Jonsson, A.-B., Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 1997. 25: 639647.
  • 12
    Giannakis, E., Jokiranta, T. S., Ormsby, R. J., Duthy, T. G., Male, D. A., Christiansen, V. A., Fischetti, V. A., Bagley, C., Loveland, B. E. and Gordon, D. L., Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J. Immunol. 2002. 168: 45854592.
  • 13
    Okada, N., Liszewski, M. K., Atkinson, J. P. and Caparon, M., Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA 1995. 92: 24892493.
  • 14
    Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A. and Lusso, P., CD46 is a cellular receptor for Human Herpesvirus 6. Cell 1999. 99: 817827.
  • 15
    Karp, C. L., Wysocka, M., Wahl, L. M., Ahearn, J. M., Cuomo, P. J., Sherry, B., Trinchieri, G. and Griffin, D. E., Mechanism of suppresion of cell-mediated immunity by measles virus. Science 1996. 273: 228231.
  • 16
    Kurita-Taniguchi, M., Fukui, A., Hazeki, K., Hirano, A., Tsuji, S., Matsumoto, M., Watanabe, M., Ueda, S. and Seya, T., Functional modulation of human macrophages through CD46 (Measles Virus Receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J. Immunol. 2000. 165: 51435152.
  • 17
    Wong, T. C., Yant, S., Harder, B. J., Korte-Sarfaty, J. and Hirano, A., The cytoplasmic domains of complement regulatory protein CD46 interact with multiple kinases in macrophages. J. Leukoc. Biol. 1997. 62: 892900.
  • 18
    Wang, G., Liszewski, M. K., Chan, A. C. and Atkinson, J. P., Membrane cofactor protein (MCP; CD46): Isoform-specific tyrosine phosphorylation. J. Immunol. 2000. 164: 18391846.
  • 19
    Hirano, A., Yant, S., Iwata, K., Korte-Sarfaty, J., Seya, T., Nagasawa, S. and Wong, T. C., Human cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplasmic domain in persistent measles virus infection. J. Virol. 1996. 70: 69296936.
  • 20
    Katayama, Y., Hirano, A. and Wong, T. C., Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon. J. Virol. 2000. 74: 12521257.
  • 21
    Källstrom, H., Islam, M. S., Berggren, P. O. and Jonsson, A. B., Cell signaling by the type IV pili of pathogenic Neisseria. J. Biol. Chem. 1998. 273: 2177721782.
  • 22
    Fernández-Centeno, E., Ojeda, G., Rojo, J. M. and Portolés, P., Crry/p65, a membrane complement regulatory protein has costimulatory properties on mouse T cells. J. Immunol. 2000. 164: 45334542.
  • 23
    Kemper, C., Chan, A. A., Green, J. M., Brett, K. A., Murphy, K. M. and Atkinson, J. P., Activation of human CD4+ cells with CD3 and CD46 induces T-regulatory cell 1 phenotype. Nature 2003. 421: 388392.
  • 24
    Marie, J. C., Astier, A. L., Rivallier, P., Rabourdin-Combe, C., Wild, T. F. and Horvat, B., Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation. Nature Immunol. 2002. 3: 659666.
  • 25
    Zaffran, Y., Destaing, O., Roux, A., Ory, S., Nheu, T., Jurdic, P., Rabourdin-Combe, C. and Astier, A. L., CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 2001. 167: 67806785.
  • 26
    Astier, A., Trescol-Biémont, M.-C., Azocar, O., Lamouille, B. and Rabourdin-Combe, C., CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 2000. 164: 60916095.
  • 27
    Michel, F., Grimaud, L., Tousto, L. and Acuto, O., Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells. J. Biol. Chem. 1998. 273: 3193231938.
  • 28
    Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P. and Samelson, L. E., LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998. 92: 8392.
  • 29
    Chan, A. C., Iwashima, M., Turck, C. W. and Weiss, A., ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR 1562; chain. Cell 1992. 71: 649662.
  • 30
    Weiss, A., T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 1993. 73: 209212.
  • 31
    Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Chused, T. M. and Schwartz, R. H., Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 1987. 84: 54095413.
  • 32
    Madrenas, J., Wange, R. L., Wang, J. L., Isakov, N., Samelson, L. E. and Germain, R. N., ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995. 267: 515517.
  • 33
    Matsuda, S., Moriguchi, T., Koyasu, S. and Nishida, E., T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to Cyclosporin A. J. Biol. Chem. 1998. 273: 1237812382.
  • 34
    Crawley, J. B., Rawlinson, L., Lali, F. V., Page, T. H., Saklatvala, J. and Foxwell, B. M. J., T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J. Biol. Chem. 1997. 272: 1502315027.
  • 35
    Rincón, M., Enslen, H., Reingeaud, J., Recht, M., Zapton, T., Su, M. S. S., Penix, L. A., Davis, R. J. and Flavell, R. A., Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 1998. 17: 28172829.
  • 36
    Zhang, S. and Kaplan, M. H., The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J. Immunol. 2000. 165: 13471380.
  • 37
    Wigzell, H., Specific affinity fractionation of lymphocytes using glass or plastic bead columns. Scand. J. Immunol. 1976. 5 (Suppl. 5): 2330.